Skip to main content

CORRECTION article

Front. Immunol., 12 October 2022
Sec. Molecular Innate Immunity
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1047951

Corrigendum: Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes

This article is a correction to:

  1. Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes

    1. Read original article
Wang Zhang&#x;Wang Zhang1†Ye Yuan&#x;Ye Yuan1†Xiang LiXiang Li1Jiao LuoJiao Luo1Zhanmei ZhouZhanmei Zhou1Lei YuLei Yu2Guobao Wang*Guobao Wang1*
  • 1Renal Division, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China
  • 2Department of Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China

A Corrigendum on
Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes.

By Zhang W, Yuan Y, Li X, Luo J, Zhou Z, Yu L and Wang G (2022). Front. Immunol. 13:900963. doi: 10.3389/fimmu.2022.900963

In the published article, there was an error in the Funding statement The grant number was incorrect. The correct Funding statement appears below:

“The research was funded by the National Natural Science Foundation of China (No. 81870489)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: IgA nephropathy, intestine immunity, extracellular vesicle (EV), immunosuppressive therapy, Peyer’s patches

Citation: Zhang W, Yuan Y, Li X, Luo J, Zhou Z, Yu L and Wang G (2022) Corrigendum: Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes. Front. Immunol. 13:1047951. doi: 10.3389/fimmu.2022.1047951

Received: 19 September 2022; Accepted: 27 September 2022;
Published: 12 October 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhang, Yuan, Li, Luo, Zhou, Yu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guobao Wang, nfyywanggb@163.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.